LED3 Lecture: Chemical Biology of Nucleic Acids

The Leiden Early Drug Discovery & Development (LED3) network is a collaboration between Leiden University’s Institute of Biology (IBL), Leiden Institute of Chemistry (LIC), and the Leiden Academic Centre for Drug Research (LACDR).

LED3 drives the discovery of innovative drug targets, molecules, and concepts to develop safer, more effective treatments for diseases like cancer, cardiovascular, neurodegenerative, and infectious conditions.

By combining expertise across early drug discovery stages, LED3 enhances understanding of molecular and cellular interactions, advancing novel approaches to drug development.

Located near the Leiden Bio Science Park and LUMC, LED3 partners with academia and industry to accelerate drug discovery and development.

Join a lecture by Andrea Rentmeister, a researcher in the field of chemical biology, as part of the LED3 (Leiden Drug Discovery and Development) series.

Andrea Rentmeister’s research focuses on developing methods to modify RNA with unparalleled precision.

This lecture promises to delve into the intersection of chemistry and biology, offering insights into how Rentmeister’s techniques are shaping the future of personalized medicine and targeted therapies.